510(k) Report

510(k) · Cleared

Cleared

Gem-Stim Combo Stimulator

K122948510(k) SpecialCleared Dec 21, 201288-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gemore Technology Co, Ltd. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Dec 21, 2012 as substantially equivalent to K042559 (Gemore Technology Co, Ltd., 2004) after an 88-day review. Its family tree reaches back 4 generations to 1992.

Decided
Dec 21, 2012
Review
88 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K921441 (1992). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK921441 Interferential Stimulator Model Inf 4150/aBiomedical Life Systems, Inc. · 1992
  2. 3 generations backK952683 Apex Medical Corp. Portable Interferential Stimulation DeviceWholesale Medical Imports, Inc. · 1997
  3. 2 generations backK032719 GM3 Series IF Tens, Model GM3X2IF (Where X IS a Parameter of…Gemore Technology Co, Ltd. · 2003
  4. 1 generation backK042559 Gem-Twin Tens/ Models GM3XY/ZGemore Technology Co, Ltd. · 2004
  5. This deviceK122948 Gem-Stim Combo StimulatorGemore Technology Co, Ltd. · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K921441Interferential Stimulator Model Inf 4150/aBiomedical Life Systems, Inc.1992—
−3K952683Apex Medical Corp. Portable Interferential Stimulation DeviceWholesale Medical Imports, Inc.1997—
−2K032719GM3 Series IF Tens, Model GM3X2IF (Where X IS a Parameter of Different Housing)Gemore Technology Co, Ltd.2003—
−1K042559Gem-Twin Tens/ Models GM3XY/ZGemore Technology Co, Ltd.2004—
0 (this device)K122948Gem-Stim Combo StimulatorGemore Technology Co, Ltd.2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
200220
200320
FIG. 1 — Lineage of K122948, 1992–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042559Gem-Twin Tens/ Models GM3XY/Z
Summary page 1
…ator. Regulatory Class: 11 Product Code: GZJ, IPF, and LIH 3. Information of the 510(k) Cleared Device (Predicate Device)i: Gemore GEM-TWIN TENS/ Model GM38Y/Z (K042559). 4. Device Descriotion: The GEM-STIM Combo Stimulator; Model: GM304/GM504/GM384/GM394 is the combina- tion of transcutaneo…
Gemore Technology Co, Ltd.2004—

Also cleared against K042559: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 6.7 years on median.
  • None of the 10 ancestors has a recall.
  • 1 other device also cites its predicate K042559.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

<1> For Transcutaneous electrical nerve stimulator.

This device is a prescription device and only for symptomatic relief of chronic intractable pain.

<2> For Power Muscle Stimulator.

Relaxation of muscle spasms.

Prevention or retardation of disuse atrophy.

Increasing local blood circulation.

Muscle re-education.

Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis.

Maintaining or increasing range of motion.

<3> For Interferential Stimulator.

The device is an interferential stimulator with TENS indications used for symptomatic relief and management of chronic intractable pain.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K122948: Gem-Stim Combo Stimulator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K122948

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026